February CHR VOICE Digest
Based on feedback from our readers, each month we will be highlighting what we consider the most important news for fertility patients and professionals working in the field. Do you have a topic you would love covered in next month’s VOICE? We would love to hear your feedback by emailing firstname.lastname@example.org
In this months CHR VOICE, we cover:
Travel rules for long distance patients
National data suggest that the current COVID-19 wave in the U.S. is quickly abating (for more on this subject, later in this issue of THE VOICE). In parallel, New York and other states, including California, have announced the impending lifting of many restrictions, hopefully denoting a small first step toward normalization of life in the nation. At the same time, new concerns have arisen, with discovery of mutated strains of the SARS-CoV-2 virus with apparently more efficient contagion and, possibly, also higher disease severity (i.e., mortality).
For CHR this means that the center will, for the foreseeable future, continue the status quo in how patient care is provided. We have seen an almost full recovery in the ability to travel among our domestic long-distance patients. The same applies to our Canadian patients, though they may require a letter of “medical necessity” from CHR; but our overseas patients, still, experience significant difficulties and conditions vary between countries of origin. In many countries, a letter of “medical necessity,” allows patients to obtain a special medical visa from a U.S consulate. New worldwide travel restrictions to the U.S., in addition, require a negative PCR test for the virus within three days of travel.
Long-distance patients who have questions about their travel to CHR and/or need help in making travel arrangements to and/or hotel reservations in New York City (many hotels are still closed), please speak to your coordinator at CHR. If you are not yet a CHR patients and have questions, please call our hot line at 1-212-994-4400 or e-mail us at email@example.com
Also included in the February VOICE:
- Preliminary 2020 IVF Cycle Outcomes
- Why has it become so difficult to believe experts?
- A word about COVID-19 testing
- New information on COVID-19 in pregnancy: Interpretation maters!
- Can COVID-19 affect male fertility?
- Are more women freezing their eggs during COVID-19?
- Important new observations about placental physiology, protecting offspring from viral infections
- Low dose aspirin in infertility and preventing miscarriage
- Is endometriosis an autoimmune disease?
- Is third-party semen donation out of control?
- Does obstructive sleep apnea cause male infertility?
- Does IVF increase ovarian cancer?
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over 17,800 babies into the world.Discover your treatment options
- Breaking News in ScienceLetter to President Biden and Secretary Designate of HHS, Xavier Becerra In a published letter (Santoro et al Reprod Sciences 2021; https:/doi.org/10.1007/s43032-021-00491-9), a
- More On COVID-19DOES THE BRITISH STRAIN B.1.1.7 INCREASE MORTALITY OVER D614G? A just published study by British investigators claims that not only infectivity of the
- Mild Ovarian StimulationTwo prominent voices in the fertility field known as longstanding supporters of mild ovarian stimulation were at it once again (Nargund and Fauser, Reprod Biomed Online 2020;41:569-571) when
- Brief Case Studies in Clinical InfertilityIs there a place for DHEA and CoQ10 in women undergoing “planned” egg-freezing? At CHR, women undergoing egg-freeing cycles undergo a very